High-resolution serum proteomic features for ovarian cancer detection

Endocrine-Related Cancer

Volumn 11, Issue 2, 2004, Pages 163-178

  Conrads, T P ^a   Fusaro, V A ^b,c   Ross, S ^b   Johann, D ^b,c   Rajapakse, V ^b,c   Hitt, B A ^d   Steinberg, S M ^c   Kohn, E C ^c   Fishman, D A ^e   Whiteley, G ^a   Barrett, J C ^c   Liotta, L A ^c   Petricoin III, E F ^b   Veenstra, T D ^a  

^a SAIC FREDERICK INC   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Correlogic Systems Inc ^*  (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ANALYTICAL ERROR; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MASS SPECTROMETRY; MOLECULAR WEIGHT; OVARY CANCER; PATTERN RECOGNITION; PROTEOMICS; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY; SERUM; UNITED STATES; VALIDATION PROCESS;

BLOOD PROTEINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 2942581832     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0110163     Document Type: Review

References (16)

1. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z & Wright GL Jr 2002 Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Research 62 3609-3614.
2. Agresti A 1990 Categorical Data Analysis. New York: Wiley.
3. Cohen LS, Escobar PF, Scharm C, Glimco B & Fishman DA 2001 Three-dimensional power doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. Gynecologic Oncology 82 40-48.
4. Holland JH 1994 Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence. Cambridge, MA: MIT Press.
5. Hutchens TW & Yip TT 1993 New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Communications in Mass Spectrometry 7 576-580.
6. Kohonen T 1990 The self-organizing map. Proceedings of the IEEE 78 1464-1480.
7. Li J, Zhang Z, Rosenzweig J, Wang YY & Chan DW 2002 Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clinical Chemistry 48 1296-1304.
8. Mehta A, Ross S, Lowenthal M, Fusaro V, Fishmann D, Petricoin E & Liotta L 2003 Biomarker amplification by serum carrier protein binding. Disease Markers 19 1-10.
9. Menon U & Jacobs IJ 2000 Recent developments in ovarian cancer screening. Current Opinion in Obstetrics and Gynecology 12 39-42.
10. Niloff JM, Knapp RC, Schaetzl E, Reynolds C & Bast RC Jr 1984 Ca125 antigen levels in obstetric and gynecologic patients. Obstetrics and Gynecology 64 703-707.
11. Ozols RF, Rubin SC, Thomas GM & Robboy SJ 2001 Epithelial ovarian cancer. In Principles and Practice of Gynecological Oncology, 3rd edn, pp. 165-182. Eds WJ Hoskins, CA Perez & RC Young. New York: Lippincott, Williams and Wilkins.
12. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC & Liotta LA 2002a Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 572-577.
13. Petricoin EF 3rd, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM & Kohn EC 2002 Serum proteomic patterns for detection of prostate cancer. Journal of the National Cancer Institute 94 1576-1578.
14. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP & Veenstra TD 2003 Characterization of the low molecular weight human serum proteome. Molecular and Cellular Proteomics 2 1096-1103.
15. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM & Carbone DP 2003 Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362 433-439.
16. Zurawski VR Jr, Orjaseter H, Andersen A & Jellum E 1988 Elevated serum CA-125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. International Journal of Cancer 42 677-680.